MMP2 and chronic kidney disease: Paricalcitol treatment effectively inhibited calcium and phosphate induced up-regulation of MMP-2 mRNA in both control (p<0.05) and CKD arteries (p<0.01), while calcitriol treatment did not produce significant changes in MMP-2 gene expression.